Practique Clinique et Investigation

Home

Practique Clinique et Investigation (Clinical Practice & Investigation) from June, 2019 is an International multidisciplinary, peer reviewed scholarly journal that provides an open access platform for the worldwide distribution of original and novel scientific manuscripts/articles based on the various aspects of the adept practical approaches to disease management. The priority of the journal is to publish manuscripts that provide useful insights into the real time efficacy and persisting lacunae in the various principles, tools and techniques involved in the diagnosis and treatment of acute and chronic diseases. The journal serve as a bond between the clinical and medical community and the general society by dispersing scientific advancements in medical and clinical research.

Publishing fees
At this stage, the submission and publication of manuscripts is at huge discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).


COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019


 

Acceptance Rate
75%
Days to process
45
Days to publish
10
Total Articles
19

Recently Published Articles

Research Article | Volume 2, Issue 2 | Open Access
Correlations among the RTS, ISS and TRISS trauma indices in different types of chest injury

Jose Maria Pereira de Godoy | Francisco de Assis Cury | André Luís Baitelo| Maria de Fatima Guerreiro Godoy

Research Article | Volume 2, Issue 2 | Open Access
Physical and Rehabilitation Physicians’ Perception and Attitude Towards Mobile Health Application in Saudi Arabia

Bander Alkhudairi | Mohammed Alkarni

Review Article | Volume 2, Issue 2 | Open Access
Diagnosis and Management of Nosocomial Sinusitis in Critical Care Units: Review of Literature

Nahla Shaaban Khalil

Research Article | Volume 2, Issue 2 | Open Access
Correlation of Salivary Stone Disease with an imbalance of Bone Remodeling Processes

Marina Vladlenovna Kozlova | Ashot Musaelovich Mkrtumyan | Anastasia Sergeevna Belyakova

Research Article | Volume 2, Issue 2 | Open Access
The Impact of Electronic Gadget Uses with Academic Performance among Secondary School Students

Noratikah Othman, Muhammad Khairuz Suhaidi Bin Kelana and Thandar Soe Sumaiyah Jamaludin

Research Article | Volume 2, Issue 2 | Open Access
Recovery, Rehabilitation Drug Treatment and Reintegration in the Community Programs: Good Practices Transfer into European Countries

Molina- Fernández AJ | Gil Rodríguez F | Cuenca Montesino ML

Research Article | Volume 2, Issue 2 | Open Access
A Review on Complications of H1N1 Infection and Possible Moieties for Treatment

Retracted

Review Article | Volume 2, Issue 1 | Open Access
Patient Satisfaction in Bangladesh: Most Important but Mostly Overlooked

AK Mohiuddin and M Nasirullah

Proceedings | Volume 2, Issue 1 | Open Access
Pharmacist’s Role in Patient Safety

Raj Kumar Sharma

Case Report | Volume 2, Issue 1 | Open Access
Richter’s Hernia: A Case Report

Gurmeet Singh Sarla

Aims & Scope

Practique Clinique et Investigation (Clinical Practice & Investigation) is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials, clinical practice and clinical research. As a peer-reviewed, tri-annually publication. It provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase 1 trials through to post-marketing studies and pharmaco-economic research.

Each and every year new therapeutic entities enter for clinical use, only one of every 10,000 potential medicines survive the development and approval process. The process of clinical research is highly expensive, involved and complex, with huge demands placed on investigators to deliver robust, reproducible data and to meet the exacting requirements of regulatory authorities.

The scope of the journal:

  • Implementation of complementary therapies (CTs) in the clinical setting
  • Legal and ethical concerns
  • Evaluative accounts of therapy in practice
  • Philosophical analysis of emergent social trends in CTs
  • Excellence in clinical judgement
  • Problem management
  • Therapy information
  • Policy development and management of change in order to promote safe and efficacious clinical practice.
  • Clinical study design and methodology
  • Overviews of the clinical progress of new drugs or drug classes
  • Clinical progress for specific diseases or therapeutic areas
  • Findings in Phase I to IV clinical studies
  • Healthcare outcomes and pharmacoeconomics
  • Patient stratification and individualized therapies
  • Commentary on trials in progress
  • Drug safety issues and adverse event monitoring
  • Biomarkers in clinical trials
  • Regulatory issues
  • Clinical trial data management and statistics